| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| MRMMEDIROM Healthcare Technologies Inc. | 13.83M | 1.75 | 0.06 | 21.55% | 1.75% | 22.24% | 3.33 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 3.43B | 3.91B | 3.34B | 5.41B | 6.95B | 6.83B | 8.3B |
| Revenue Growth % | - | 0.14% | -0.14% | 0.62% | 0.29% | -0.02% | 0.22% |
| Cost of Goods Sold | 2.48B | 2.96B | 2.91B | 3.99B | 5.05B | 5.26B | 6.05B |
| COGS % of Revenue | 0.72% | 0.76% | 0.87% | 0.74% | 0.73% | 0.77% | 0.73% |
| Gross Profit | 956.87M | 950.76M | 428.95M | 1.42B | 1.9B | 1.57B | 2.25B |
| Gross Margin % | 0.28% | 0.24% | 0.13% | 0.26% | 0.27% | 0.23% | 0.27% |
| Gross Profit Growth % | - | -0.01% | -0.55% | 2.3% | 0.34% | -0.18% | 0.43% |
| Operating Expenses | 850.61M | 905.21M | 1.18B | 1.89B | 1.81B | 1.96B | 2.26B |
| OpEx % of Revenue | 0.25% | 0.23% | 0.35% | 0.35% | 0.26% | 0.29% | 0.27% |
| Selling, General & Admin | 842.82M | 871.86M | 1.07B | 1.81B | 1.81B | 1.96B | 2.24B |
| SG&A % of Revenue | 0.25% | 0.22% | 0.32% | 0.33% | 0.26% | 0.29% | 0.27% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 33.35M | 106.5M | 75.21M | 0 | 0 | 22.87M |
| Operating Income | 114.05M | 78.9M | -746.09M | -470.59M | 96.97M | -391.58M | -18.1M |
| Operating Margin % | 0.03% | 0.02% | -0.22% | -0.09% | 0.01% | -0.06% | -0% |
| Operating Income Growth % | - | -0.31% | -10.46% | 0.37% | 1.21% | -5.04% | 0.95% |
| EBITDA | 158.31M | 125.07M | -683.8M | -344.34M | 281.02M | -138.98M | 271.94M |
| EBITDA Margin % | 0.05% | 0.03% | -0.2% | -0.06% | 0.04% | -0.02% | 0.03% |
| EBITDA Growth % | - | -0.21% | -6.47% | 0.5% | 1.82% | -1.49% | 2.96% |
| D&A (Non-Cash Add-back) | 44.27M | 46.17M | 62.29M | 126.24M | 184.06M | 252.59M | 290.04M |
| EBIT | 107.41M | 46.33M | -613.46M | -402.53M | 189.57M | 57.49M | 97.46M |
| Net Interest Income | -14.7M | -12.26M | -11.9M | -11.11M | -3.73M | -35.76M | -49.74M |
| Interest Income | 785K | 1.34M | 1.33M | 839K | 6.07M | 1.11M | 8K |
| Interest Expense | 15.48M | 13.59M | 13.23M | 11.95M | 9.8M | 36.87M | 49.74M |
| Other Income/Expense | -22.48M | -1.05M | 119.4M | 56.11M | 82.81M | 412.2M | 65.81M |
| Pretax Income | 91.56M | 33.3M | -626.69M | -414.48M | 179.77M | 20.62M | 47.71M |
| Pretax Margin % | 0.03% | 0.01% | -0.19% | -0.08% | 0.03% | 0% | 0.01% |
| Income Tax | 25.25M | 15.96M | -87.52M | 576.25M | 30.81M | -94.43M | -90.48M |
| Effective Tax Rate % | 0.72% | 0.52% | 0.86% | 2.39% | 0.83% | 5.58% | 3.12% |
| Net Income | 66.31M | 17.34M | -539.17M | -990.73M | 148.97M | 115.05M | 148.76M |
| Net Margin % | 0.02% | 0% | -0.16% | -0.18% | 0.02% | 0.02% | 0.02% |
| Net Income Growth % | - | -0.74% | -32.1% | -0.84% | 1.15% | -0.23% | 0.29% |
| Net Income (Continuing) | 66.31M | 17.34M | -539.17M | -990.73M | 148.97M | 115.05M | 138.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 5.08M | 254.79M |
| EPS (Diluted) | 14.04 | 4.06 | -133.97 | -203.13 | 27.23 | 22.27 | 28.52 |
| EPS Growth % | - | -0.71% | -34% | -0.52% | 1.13% | -0.18% | 0.28% |
| EPS (Basic) | 18.06 | 4.63 | -133.97 | -203.13 | 30.54 | 23.64 | 29.13 |
| Diluted Shares Outstanding | 4.72M | 4.27M | 4.02M | 4.88M | 5.47M | 5.17M | 5.85M |
| Basic Shares Outstanding | 4.72M | 4.27M | 4.02M | 4.88M | 5.47M | 5.17M | 5.11M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 934.04M | 1.38B | 2.09B | 1.38B | 2.36B | 1.76B | 2.71B |
| Cash & Short-Term Investments | 244.71M | 552.14M | 1.47B | 377.12M | 605.95M | 132.85M | 335.56M |
| Cash Only | 211.69M | 513.62M | 1.44B | 370.62M | 605.45M | 106.35M | 329.4M |
| Short-Term Investments | 33.02M | 38.52M | 32.52M | 6.5M | 500K | 500K | 6.16M |
| Accounts Receivable | 283M | 337.05M | 148.54M | 312.3M | 534.69M | 1.23B | 2B |
| Days Sales Outstanding | 30.09 | 31.48 | 16.22 | 21.07 | 28.06 | 65.64 | 88.04 |
| Inventory | 6.4M | 5.51M | 7.96M | 18.7M | 114.11M | 139.98M | 151.64M |
| Days Inventory Outstanding | 0.94 | 0.68 | 1 | 1.71 | 8.24 | 9.72 | 9.14 |
| Other Current Assets | 359.88M | 436.54M | 411.28M | 563.01M | 815.82M | 0 | 217.17M |
| Total Non-Current Assets | 3.59B | 3.38B | 3.63B | 4.37B | 4.38B | 5.09B | 5.38B |
| Property, Plant & Equipment | 2.27B | 2B | 1.81B | 2.25B | 2.38B | 2.54B | 2.51B |
| Fixed Asset Turnover | 1.51x | 1.96x | 1.84x | 2.41x | 2.92x | 2.69x | 3.31x |
| Goodwill | 63.95M | 78.28M | 150.72M | 600.33M | 539.49M | 484.56M | 389.13M |
| Intangible Assets | 76.28M | 77.64M | 97.61M | 391.04M | 403.67M | 920.7M | 1.14B |
| Long-Term Investments | 51.98M | 14.04M | 500K | 53.02M | 53.02M | 81.54M | 87.42M |
| Other Non-Current Assets | 1.12B | 1.21B | 1.56B | 1.08B | 1.01B | 961.14M | 973.46M |
| Total Assets | 4.52B | 4.76B | 5.71B | 5.75B | 6.75B | 6.85B | 8.09B |
| Asset Turnover | 0.76x | 0.82x | 0.58x | 0.94x | 1.03x | 1.00x | 1.03x |
| Asset Growth % | - | 0.05% | 0.2% | 0.01% | 0.17% | 0.02% | 0.18% |
| Total Current Liabilities | 2.35B | 2.26B | 2.65B | 3.2B | 3.64B | 3.56B | 4.18B |
| Accounts Payable | 141.32M | 122.59M | 67.02M | 230.9M | 207.58M | 137.7M | 1.01B |
| Days Payables Outstanding | 20.83 | 15.13 | 8.4 | 21.1 | 15 | 9.56 | 61.16 |
| Short-Term Debt | 413.74M | 371.57M | 242.28M | 162.25M | 99.17M | 500.42M | 1.11B |
| Deferred Revenue (Current) | 0 | 0 | 1000K | 1000K | 0 | 1000K | 1000K |
| Other Current Liabilities | 648.78M | 616.53M | 162.13M | 459.54M | 1.18B | 370.21M | 414.7M |
| Current Ratio | 0.40x | 0.61x | 0.79x | 0.43x | 0.65x | 0.49x | 0.65x |
| Quick Ratio | 0.39x | 0.61x | 0.78x | 0.43x | 0.62x | 0.45x | 0.61x |
| Cash Conversion Cycle | 10.2 | 17.03 | 8.82 | 1.68 | 21.31 | 65.8 | 36.02 |
| Total Non-Current Liabilities | 2.29B | 1.89B | 2.57B | 2.76B | 3.16B | 3.07B | 2.72B |
| Long-Term Debt | 342.77M | 150.53M | 668.38M | 746.59M | 1.15B | 1.05B | 764.2M |
| Capital Lease Obligations | 1.32B | 1.14B | 992.89M | 1.13B | 1.21B | 1.33B | 1.29B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 621.8M | 607.39M | 908.35M | 889.61M | 802.36M | 687.2M | 632.51M |
| Total Liabilities | 4.64B | 4.16B | 5.22B | 5.96B | 6.81B | 6.63B | 6.9B |
| Total Debt | 2.85B | 2.36B | 2.56B | 2.79B | 3.23B | 3.65B | 3.96B |
| Net Debt | 2.64B | 1.85B | 1.12B | 2.42B | 2.63B | 3.54B | 3.63B |
| Debt / Equity | - | 3.94x | 5.21x | - | - | 16.90x | 3.33x |
| Debt / EBITDA | 18.00x | 18.89x | - | - | 11.50x | - | 14.55x |
| Net Debt / EBITDA | 16.66x | 14.79x | - | - | 9.34x | - | 13.34x |
| Interest Coverage | 7.36x | 5.81x | -56.38x | -39.38x | 9.89x | -10.62x | -0.36x |
| Total Equity | -117.56M | 600.06M | 491.26M | -208.34M | -59.38M | 215.96M | 1.19B |
| Equity Growth % | - | 6.1% | -0.18% | -1.42% | 0.71% | 4.64% | 4.5% |
| Book Value per Share | -24.90 | 140.45 | 122.06 | -42.72 | -10.85 | 41.80 | 203.03 |
| Total Shareholders' Equity | -117.56M | 600.06M | 491.26M | -208.34M | -59.38M | 210.88M | 933.27M |
| Common Stock | 245.1M | 595.1M | 1.18B | 1.22B | 1.22B | 20M | 352.62M |
| Retained Earnings | -722.64M | -705.31M | -1.7B | -2.69B | -2.55B | 80.28M | 229.04M |
| Treasury Stock | -3M | -3M | -3M | -3M | -3M | -3M | -3M |
| Accumulated OCI | -278K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 5.08M | 254.79M |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 141.87M | 7.87M | -366.42M | -557.23M | -685.7M | -631.74M | -1.33B |
| Operating CF Margin % | 0.04% | 0% | -0.11% | -0.1% | -0.1% | -0.09% | -0.16% |
| Operating CF Growth % | - | -0.94% | -47.56% | -0.52% | -0.23% | 0.08% | -1.11% |
| Net Income | 66.31M | 17.34M | -539.17M | -990.73M | 148.97M | 115.05M | 138.19M |
| Depreciation & Amortization | 44.27M | 46.17M | 62.29M | 126.24M | 184.06M | 252.59M | 290.04M |
| Stock-Based Compensation | 149K | 0 | 0 | 196.85M | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -101.64M | -188.71M |
| Other Non-Cash Items | 151.54M | 42.88M | -156.66M | 1.9M | -968.78M | -1.4B | -1.57B |
| Working Capital Changes | -120.39M | -98.52M | 267.12M | 108.5M | -49.94M | 498.76M | 1.97M |
| Change in Receivables | 30.17M | -66.88M | 189.14M | -37.02M | -222.38M | 580.68M | 299.96M |
| Change in Inventory | 6.92M | 892K | -2.44M | -2.44M | -95.41M | -25.87M | -10.61M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | -69.88M | 876.51M |
| Cash from Investing | -79.39M | -37.93M | -139.6M | -83.94M | 580.44M | -328.58M | 361.39M |
| Capital Expenditures | -34.3M | -7.41M | -73.56M | -95.65M | -120.74M | -135.84M | -71.41M |
| CapEx % of Revenue | 0.01% | 0% | 0.02% | 0.02% | 0.02% | 0.02% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 15.18M | -27.32M | 33.15M | 30.39M | 849.18M | -774.41M | -478.18M |
| Cash from Financing | -74.47M | 331.99M | 1.43B | -427.95M | 340.1M | 461.21M | 1.19B |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 180M | -126.09M | -125.06M | -176.87M | -162.25M | 160.29M | 0 |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | 107.57M | 464K | -439.98M | -652.88M | -806.44M | -767.58M | -1.9B |
| FCF Margin % | 0.03% | 0% | -0.13% | -0.12% | -0.12% | -0.11% | -0.23% |
| FCF Growth % | - | -1% | -949.22% | -0.48% | -0.24% | 0.05% | -1.47% |
| FCF per Share | 22.78 | 0.11 | -109.32 | -133.86 | -147.41 | -148.56 | -324.10 |
| FCF Conversion (FCF/Net Income) | 2.14x | 0.45x | 0.68x | 0.56x | -4.60x | -5.49x | -8.95x |
| Interest Paid | 17.01M | 11.87M | 10.22M | 10.87M | 7.54M | 34.58M | 47.56M |
| Taxes Paid | 14.78M | 24.34M | 7M | 45.51M | 30.81M | 52.1M | 12.78M |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | 7.19% | -98.81% | -700.38% | - | 146.95% | 21.19% |
| Return on Invested Capital (ROIC) | 3.39% | 2.38% | -27.55% | -18.44% | 3.04% | -9.29% | -0.32% |
| Gross Margin | 27.87% | 24.33% | 12.84% | 26.16% | 27.36% | 22.98% | 27.07% |
| Net Margin | 1.93% | 0.44% | -16.13% | -18.31% | 2.14% | 1.69% | 1.79% |
| Debt / Equity | - | 3.94x | 5.21x | - | - | 16.90x | 3.33x |
| Interest Coverage | 7.36x | 5.81x | -56.38x | -39.38x | 9.89x | -10.62x | -0.36x |
| FCF Conversion | 2.14x | 0.45x | 0.68x | 0.56x | -4.60x | -5.49x | -8.95x |
| Revenue Growth | - | 13.84% | -14.5% | 61.89% | 28.54% | -1.81% | 21.55% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Franchise | 175.44M | - | 645.73M | 523.33M | 316.65M |
| Franchise Growth | - | - | - | -18.96% | -39.49% |
| Sublease revenue | - | 437.98M | 411.7M | 364.37M | 308.31M |
| Sublease revenue Growth | - | - | -6.00% | -11.50% | -15.38% |
| Other franchise revenues | - | 247.35M | 630.23M | 181.76M | 179.35M |
| Other franchise revenues Growth | - | - | 154.79% | -71.16% | -1.32% |
| Other revenues | - | 43.97M | 427.03M | 200.4M | 160.63M |
| Other revenues Growth | - | - | 871.30% | -53.07% | -19.85% |
| Royalty income | - | 209.85M | 403.17M | 181.42M | 156.32M |
| Royalty income Growth | - | - | 92.12% | -55.00% | -13.83% |
| Staffing service revenue | - | 263.96M | 86.97M | 136.57M | 76.84M |
| Staffing service revenue Growth | - | - | -67.05% | 57.02% | -43.74% |
| Franchise fees | - | 199.89M | - | - | - |
| Franchise fees Growth | - | - | - | - | - |
| Franchisor Owned Outlet | 2.03B | - | - | - | - |
| Franchisor Owned Outlet Growth | - | - | - | - | - |
| Sublease Revenue | 492.37M | - | - | - | - |
| Sublease Revenue Growth | - | - | - | - | - |
| Staffing Service Revenue | 254.28M | - | - | - | - |
| Staffing Service Revenue Growth | - | - | - | - | - |
| Other Franchise | 187.3M | - | - | - | - |
| Other Franchise Growth | - | - | - | - | - |
| Royalty | 179.75M | - | - | - | - |
| Royalty Growth | - | - | - | - | - |
| Product And Service Other | 25.67M | - | - | - | - |
| Product And Service Other Growth | - | - | - | - | - |
MEDIROM Healthcare Technologies Inc. (MRM) has a price-to-earnings (P/E) ratio of 0.1x. This may indicate the stock is undervalued or faces growth challenges.
MEDIROM Healthcare Technologies Inc. (MRM) reported $15.13B in revenue for fiscal year 2024. This represents a 341% increase from $3.43B in 2018.
MEDIROM Healthcare Technologies Inc. (MRM) grew revenue by 21.5% over the past year. This is strong growth.
Yes, MEDIROM Healthcare Technologies Inc. (MRM) is profitable, generating $264.2M in net income for fiscal year 2024 (1.8% net margin).
MEDIROM Healthcare Technologies Inc. (MRM) has a return on equity (ROE) of 21.2%. This is excellent, indicating efficient use of shareholder capital.
MEDIROM Healthcare Technologies Inc. (MRM) had negative free cash flow of $2.66B in fiscal year 2024, likely due to heavy capital investments.